Thank you to all who attended the HIVLN session on September 27 @ Noon (Pacific): Incarceration to Linkage: Breaking Down Barriers to Successful Reintegration into Community Based Care, by Rose Conner and Cynthia Quinn, RN, MSN, Ryan White Part A Program, Maricopa, AZ. Please see below to view recording, presentation slides, and resources discussed during the session.
Please join us for the next HIVLN Session on October 11 @ Noon (Pacific): Non-Alcoholic Fatty Liver Disease (NAFLD) – Pressing Issues for the HIV Provider, by Edward (Lalo) Cachay, MD, MAS, Owen Clinic Hepatitis Co-Infection Program. To register, please CLICK HERE.
If you’d like subscribe to our mailing list to get future announcements and archived sessions, please click here to SUBSCRIBE.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nevada School of Medicine and the Pacific AIDS Education and Training Center. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians.
The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses may receive continuing education credit for this educational activity as the ANCC accepts AMA PRA Category 1 Credits™ through its reciprocity agreement.
Downloads and Links
- HIVLN Slide Set: Incarceration to Linkage: Breaking Down Barriers to Successful Reintegration into Community Based Care:
- New HIV Drug: Pifeltro (doravirine) Package Insert:
- New HIV Drug: Delstrigo (doravirine, lamivudine, and tenofovir disoproxil) Package Insert:
- HIVLN Session Recording: Incarceration to Linkage: Breaking Down Barriers to Successful Reintegration into Community Based Care (Click to register and view):
- Editorial: Doravirine Sets a New Standard for NNRTIs — But What Role in HIV Treatment Today? (Paul E. Sax, MD, Contributing Editor, NEJM Journal Watch, Infectious Diseases):